ESE

Analyst Note: ESCO Technologies Inc. (ESE)

Date: 2026-06-13 Event Date: 2026-06-13

1. Structural Readiness

• State: Actionable (Forming Coil)
• Conservative Entry: Not yet defined (awaiting breakout confirmation).
• Breakout Level: Not yet defined (awaiting price action above the consolidation high).
• Current Price: $343.50.
• Extension: Not applicable (price is within the consolidation range, not extended above the breakout).
• ATR Context: Current ATR is 3.1% (productive). This sits within the historical "sweet spot" (4–6% is ideal, but 3.1% indicates manageable volatility for position sizing without the elevated risk of >6% or the weakness of <2.5%).

2. Thesis Layer

• Primary Secular Thesis: Defense Modernization → Naval / Shipbuilding.
• Role & Directness: ESCO is a direct beneficiary of the U.S. Navy's modernization efforts, specifically through its Aerospace & Defense (A&D) segment. The company supplies critical filtration and fluid control systems for crewed aircraft and submarines. Crucially, the company develops elastomeric-based solutions designed to reduce the acoustic signature of U.S. naval vessels, a key requirement for modern submarine stealth and survivability.
• Evidence: Management explicitly noted entering $24 million of Virginia Class orders in the quarter for Block V.2 and Block VI content, signaling deepening engagement with the Navy's most critical asset class.
• Secondary Secular Thesis: Energy Transition & Electrification → Grid & Transmission Modernization.
• Role & Directness: Through the Utility Solutions Group (USG) and the recently acquired Megger business, ESCO provides diagnostic measurement, testing, and monitoring solutions essential for maintaining and expanding the aging electric grid.
• Evidence: Approximately 85% of segment activity is tied to utility capital spending, which management expects to remain elevated. The acquisition of Megger (expected to close Q1 FY2027) expands the company's footprint in data-driven solutions for utilities and critical infrastructure.

3. Business Overview

ESCO Technologies Inc. operates as a global provider of specialized engineered products and sophisticated systems across three primary business units: Aerospace & Defense (A&D), Utility Solutions Group (USG), and RF Shielding and Test.

• Aerospace & Defense: Focuses on advanced filtration (hydraulic filters, fluid control) and precision-machined components (bushings, pins, sleeves) for landing gear, rotor heads, and flight controls. The segment also produces micro-propulsion filters for satellites.
• *Financials:* The A&D segment accounted for 44% of total revenue in 2025. Direct and indirect sales to the U.S. Government represented 23% of total revenue in 2025.
• *Backlog:* The A&D backlog grew significantly, reaching $803.0 million at September 30, 2025, up from $385.6 million a year prior.
• Utility Solutions Group (USG): Provides diagnostic testing capabilities for high-voltage power transmission equipment. This segment is heavily leveraged to utility capital spending, which management cites as a primary driver of demand due to the strain on aging infrastructure.
• *Growth:* Net sales for the second quarter of 2026 were $309.3 million, a 33.4% increase year-over-year.
• RF Shielding and Test: Designs and manufactures specialized facilities (RF test environments, secure communication sites) and measurement accessories (antennas, probes, software).
• Strategic M&A:
• Acquisition of SM&P (April 2025): Added capabilities in measurement systems and EMS development.
• Sale of VACCO (July 2025): Divested the former A&D subsidiary VACCO Industries for ~$270 million, streamlining the portfolio.
• Pending Acquisition of Megger: Expected to close in Q1 FY2027, adding global testing and monitoring capabilities for utilities and data centers.
• Order Book Strength: Total company backlog reached $1,470.0 million at March 31, 2026, up from $1,133.6 million at September 30, 2025. New orders in the first six months of 2026 totaled $935.4 million, nearly double the $494.9 million recorded in the same period of 2025.

4. Archetype and Conviction

• Archetype: Quality Compounder.
• Fit: The company demonstrates consistent revenue growth, expanding margins (EBIT margin held at 15.0% in Q2 2026 vs 15.8% in Q2 2025, despite significant sales growth), and a rapidly expanding backlog. The strategic divestiture of VACCO and the acquisition of SM&P and Megger indicate a management team actively optimizing the portfolio for higher-margin, secular-growth end markets.
• Valuation & Financials:
• Management guidance for full-year adjusted EPS is $8.00 to $8.25.
• Forward consensus EPS for FY1 is $8.18, aligning closely with management's guidance.
• The financial spine coverage is "complete," providing a clear view of near-term earnings expectations.
• Conviction Stack:
• Thesis Strength: High. The dual exposure to Naval Shipbuilding (Virginia Class orders) and Grid Modernization (85% of USG tied to utility spend) provides a robust secular tailwind.
• Evidence Quality: Strong. Multiple primary sources (earnings transcripts, 10-Q/10-K filings) confirm record backlogs, strong order intake, and specific program wins.
• Structural Quality: The backlog growth (70.7% increase YoY as of Sept 2025) and the 64% of backlog expected to be completed in FY2026 provide high visibility for near-term revenue recognition.
• Rerating Potential: Moderate to High. As the Megger acquisition closes and the A&D backlog converts to revenue, the market may re-rate the company based on the higher growth profile of the combined entity.

5. Invalidations, Strengtheners, and Gaps

• Invalidation Triggers:
• A significant reduction in the backlog or a delay in the Megger acquisition closing beyond Q1 FY2027 would weaken the thesis.
• A sharp decline in utility capital spending or a reduction in defense appropriations affecting the Virginia Class program.
• Strengtheners:
• Confirmation of the Megger acquisition closing in Q1 FY2027 as expected.
• Further expansion of the backlog beyond the current $1.47 billion level.
• Management raising full-year EPS guidance above the $8.25 upper bound.
• Gaps in Evidence:
• Breakout Level: The specific resistance level that must be breached for a "Confirmed" status is not quantified.
• Megger Integration Details: While the acquisition is noted, specific synergies or immediate revenue impact post-closing are not detailed in the provided evidence.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: High Key evidence: Record backlog of $1.47B with 70.7% YoY growth; $24M in new Virginia Class orders for Block V.2/VI; Management guidance of $8.00-$8.25 EPS aligns with consensus; 33.4% Q2 sales growth driven by utility spending. Key risks: Execution risk on Megger acquisition closing in Q1 FY2027; potential delay in defense appropriations; consolidation volatility if breakout fails to materialize. Expected path: Management expects the Megger deal to close in Q1 FY2027, expanding the utility testing footprint. The backlog is expected to convert to revenue in FY2026, supporting the EPS guidance. Expected horizon: 6 to 12 months for the thesis to fully play out as the acquisition closes and backlog converts.